BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2334908)

  • 1. Re: Martin E. Sanders et al., Molecular Pathways of Adhesion in Spontaneous Rosetting of T-Lymphocytes to the Hodgkin's Cell Line L428.
    Flavell DJ; Wright DH
    Cancer Res; 1990 May; 50(10):3131-2. PubMed ID: 2334908
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular pathways of adhesion in spontaneous rosetting of T-lymphocytes to the Hodgkin's cell line L428.
    Sanders ME; Makgoba MW; Sussman EH; Luce GE; Cossman J; Shaw S
    Cancer Res; 1988 Jan; 48(1):37-40. PubMed ID: 3275493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen presentation by Hodgkin's disease cells.
    Fisher RI; Cossman J; Diehl V; Volkman DJ
    J Immunol; 1985 Nov; 135(5):3568-71. PubMed ID: 3876389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoplastic cells obtained from Hodgkin's disease function as accessory cells for mitogen-induced human T cell proliferative responses.
    Fisher RI; Bates SE; Bostick-Bruton F; Tuteja N; Diehl V
    J Immunol; 1984 May; 132(5):2672-7. PubMed ID: 6609204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Reed-Sternberg cell/lymphocyte rosette. I. Properties of rosettes formed between Hodgkin's cell lines and allogeneic lymphocytes.
    Flavell DJ; Wright DH
    Br J Cancer; 1989 Feb; 59(2):165-73. PubMed ID: 2495015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro stimulation of T-cell rosette formation by antiserum to thymus factor in Hodgkin's disease.
    Zółtowska A; Arendt M; Gan J
    Arch Immunol Ther Exp (Warsz); 1984; 32(1):51-7. PubMed ID: 6332594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous rosette-forming capacity of T-lymphocytes in Hodgkin's disease.
    Bodolay E; Berényi E; Sonkoly I; Szegedi G
    Acta Med Hung; 1984; 41(2-3):113-9. PubMed ID: 6611543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunology and cellular biology of Hodgkin's disease.
    Slivnick DJ; Nawrocki JF; Fisher RI
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):205-20. PubMed ID: 2663823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hodgkin's disease. Histology--immunohistology--immunology].
    Möller P
    Norm Pathol Anat (Stuttg); 1986; 51():1-77. PubMed ID: 3495783
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pathology of Hodgkin's lymphoma].
    Hansmann ML; Willenbrock K
    Verh Dtsch Ges Pathol; 2003; 87():53-7. PubMed ID: 16888894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodular sclerosing, mixed cellularity and lymphocyte-depleted variants of Hodgkin's disease are probable dendritic cell malignancies.
    Kennedy IC; Hart DN; Colls BM; Nimmo JC; Willis DA; Angus HB
    Clin Exp Immunol; 1989 Jun; 76(3):324-31. PubMed ID: 2787713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L428 cells derived from Hodgkin's disease produce E rosette-inhibiting factor.
    Katay I; Wirnitzer U; Burrichter H; von Kalle C; Schell-Frederick E; Diehl V; Schaadt M
    Blood; 1990 Aug; 76(4):791-6. PubMed ID: 2383657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory action of Hodgkin's disease patients serum on T lymphocytes E rosette forming ability (author's transl)].
    Panteghini M; Piccioli E; Migliorati T; Ruggeri G
    Ann Sclavo; 1979; 21(4):483-93. PubMed ID: 317987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The rosette test with sensitized sheep erythrocytes, acid phosphatase and alpha-naphthylacetate esterase in an acid medium: comparative immunocytochemical T-cell exhibition in Hodgkin's disease].
    Plat M; Plat U; Fleischer J; Wolf H; Palitzsch M; Hofmann R; Reinhardt U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(1):87-95. PubMed ID: 2472333
    [No Abstract]   [Full Text] [Related]  

  • 15. [T lymphocytes from patients with Hodgkin's disease suppress erythroid progenitor growth from autologous marrow].
    Hansz J; Kozłowska-Skrzypczak M; Sawiński K; Włodarczyk M
    Acta Haematol Pol; 1995; 26(2):185-93. PubMed ID: 7653224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
    Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
    Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A T cell surface molecule different from CD2 is involved in spontaneous rosette formation with erythrocytes.
    Bernard A; Aubrit F; Raynal B; Pham D; Boumsell L
    J Immunol; 1988 Mar; 140(6):1802-7. PubMed ID: 2894395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of the distribution of lymphocyte subpopulations in Hodgkin's disease.
    Borowitz MJ; Croker BP; Metzgar RS
    Cancer Treat Rep; 1982 Apr; 66(4):667-74. PubMed ID: 6210433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of correlation between skin reactivity and T lymphocytes and monocytes in Hodgkin's disease.
    Müftüoğlu AU; Yalçin B
    Acta Haematol; 1980; 63(5):286-8. PubMed ID: 6774558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of a novel gene isolated from a Hodgkin's disease cell line that is expressed early during lymphoid cell activation.
    Bennett JS; Tredway TL; Dizikes GJ; Nawrocki JF
    J Immunol; 1994 Mar; 152(5):2229-40. PubMed ID: 8133036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.